Renee Ryan and Marianne De Backer have moved on from corporate venturing vehicle Johnson & Johnson Innovation – JJDC for roles at Cala Health and Bayer respectively.

US-based healthcare company Johnson & Johnson has lost two of its most experienced investors with Renee Ryan (pictured) becoming CEO at its portfolio company Cala Health and Germany-based Bayer hiring Marianne De Backer to manage its acquisitions and licensing deals. Wearable neuromodulation device manufacturer Cala Health had completed a $50m series C round in May…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.